Ubs Group Ag Cidara Therapeutics, Inc. Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$0.64 - $0.92 $3,004 - $4,319
4,695 New
4,695 $4,000
Q2 2022

Aug 10, 2022
SELL
$0.43 - $0.91 $737 - $1,559
-1,714 Reduced 99.36%
11 $0
Q1 2022

May 16, 2022
BUY
$0.67 - $1.39 $1,148 - $2,382
1,714 Added 15581.82%
1,725 $1,000
Q4 2021

Feb 14, 2022
SELL
$1.18 - $2.18 $4 - $8
-4 Reduced 26.67%
11 $0
Q3 2021

Nov 15, 2021
SELL
$1.48 - $2.35 $8,851 - $14,055
-5,981 Reduced 99.75%
15 $0
Q2 2021

Aug 13, 2021
SELL
$1.87 - $2.7 $32,020 - $46,232
-17,123 Reduced 74.06%
5,996 $12,000
Q1 2021

May 12, 2021
SELL
$2.06 - $3.01 $3,949 - $5,770
-1,917 Reduced 7.66%
23,119 $62,000
Q4 2020

Feb 11, 2021
SELL
$1.99 - $3.25 $257,108 - $419,900
-129,200 Reduced 83.77%
25,036 $50,000
Q3 2020

Nov 12, 2020
BUY
$2.85 - $4.1 $37,508 - $53,960
13,161 Added 9.33%
154,236 $440,000
Q2 2020

Jul 31, 2020
BUY
$2.39 - $4.0 $253,889 - $424,920
106,230 Added 304.86%
141,075 $520,000
Q1 2020

May 01, 2020
BUY
$1.74 - $4.26 $56,033 - $137,184
32,203 Added 1218.89%
34,845 $87,000
Q4 2019

Feb 14, 2020
SELL
$1.77 - $3.84 $11,352 - $24,629
-6,414 Reduced 70.83%
2,642 $10,000
Q3 2019

Nov 14, 2019
BUY
$1.25 - $2.35 $413 - $777
331 Added 3.79%
9,056 $18,000
Q2 2019

Aug 14, 2019
SELL
$1.49 - $2.94 $3,200 - $6,315
-2,148 Reduced 19.76%
8,725 $14,000
Q1 2019

May 14, 2019
BUY
$2.35 - $3.27 $3,362 - $4,679
1,431 Added 15.16%
10,873 $29,000
Q4 2018

Feb 14, 2019
BUY
$2.1 - $4.5 $10,086 - $21,613
4,803 Added 103.54%
9,442 $22,000
Q3 2018

Nov 14, 2018
SELL
$3.7 - $5.25 $9,590 - $13,608
-2,592 Reduced 35.85%
4,639 $20,000
Q2 2018

Aug 14, 2018
BUY
$3.75 - $6.05 $12,596 - $20,321
3,359 Added 86.75%
7,231 $38,000
Q1 2018

May 15, 2018
BUY
$4.0 - $8.15 $9,888 - $20,146
2,472 Added 176.57%
3,872 $15,000
Q4 2017

Feb 14, 2018
BUY
$6.35 - $8.75 $8,890 - $12,250
1,400 New
1,400 $10,000
Q3 2017

Nov 14, 2017
SELL
$5.75 - $8.1 $799 - $1,125
-139 Closed
0 $0
Q2 2017

Aug 14, 2017
SELL
N/A
-1,176 Reduced 89.43%
139 $1,000
Q1 2017

Nov 14, 2017
BUY
N/A
1,315
1,315 $10,000

About Cidara Therapeutics, Inc.

CDTX Quotes by TradingView
  • Ticker CDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,075,696
  • Market Cap $1.24B
  • Description
  • Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...
More about CDTX
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email